Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

about

Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.

P2860

Q38823772-AEEA778D-B836-4B38-92D0-4B86640C20DD

P2860

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

Item

http://www.wikidata.org/entity/Q36491662

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@ast

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@en

type

Item

label

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@ast

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@en

prefLabel

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@ast

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@en

P1476

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

@en

P2093

Andy Göbel

http://www.w3.org/2001/XMLSchema#string

Maria Wilke

http://www.w3.org/2001/XMLSchema#string

Martina Rauner

http://www.w3.org/2001/XMLSchema#string

Norbert Schütze

http://www.w3.org/2001/XMLSchema#string

Peggy Benad-Mehner

http://www.w3.org/2001/XMLSchema#string

Peyman Hadji

http://www.w3.org/2001/XMLSchema#string

Susanne Füssel

http://www.w3.org/2001/XMLSchema#string

Tilman D Rachner

http://www.w3.org/2001/XMLSchema#string

P2860

Structural mechanism for statin inhibition of HMG-CoA reductase

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.

Clinical features of metastatic bone disease and risk of skeletal morbidity.

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.

Statin use and reduced cancer-related mortality.

Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.

Antitumor effects of bisphosphonates.

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.

P304

10-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JBO.2014.02.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lorenz C Hofbauer

P577

2014-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260250558

http://www.w3.org/2001/XMLSchema#string

P698

26909293

http://www.w3.org/2001/XMLSchema#string

P932

4723419

http://www.w3.org/2001/XMLSchema#string

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

about

P2860

P2860

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932